Search

Your search keyword '"Javier Muñoz"' showing total 764 results

Search Constraints

Start Over You searched for: Author "Javier Muñoz" Remove constraint Author: "Javier Muñoz" Language undetermined Remove constraint Language: undetermined
764 results on '"Javier Muñoz"'

Search Results

4. Autoimagen de España y nacionalismo en 'El Sol de Sevilla', de Pablo de Olavide (1800)

5. Abstract P2-23-16: Clinico-Pathological and Molecular Characterization of HER2-Enriched Breast Tumors Independently of HER2 Status

6. inconstante corregido de Pablo de Olavide, primera bildungsroman hispana y americana conocida

7. Managing Ibrutinib-Intolerant Patients With B-Cell Malignancies

9. CollisionGP: Gaussian Process-Based Collision Checking for Robot Motion Planning

10. UPPER ELEVATIONAL RANGE EXTENSION OF Sceloporus utiformis COPE, 1864 (SQUAMATA: PHRYNOSOMATIDAE) IN THE SIERRA DE MANANTLÁN BIOSPHERE RESERVE, MEXICO

11. Vibration motor stimulation device in smart leggings that promotes motor performance in older people

12. Between Autofiction and the Expressive Theory of Art: Efectos del amor propio by Miguel Álvarez De Sotomayor (c. 1810)

13. José Marchena en defensa de la libre sexualidad humana: el «Fragmento de Petronio» (1800)

14. El trabajo en equipo como elemento imprescindible en el periodismo de datos

15. Beneficial Effects of Mifepristone Treatment in Patients with Breast Cancer Selected by the Progesterone Receptor Isoform Ratio: Results from the MIPRA Trial

18. Plant water use strategy is strongly constrained by species size in Mediterranean ecosystems

19. Biomarkers of delirium risk in older adults: a systematic review and meta-analysis

20. DLST mutations in pheochromocytoma and paraganglioma cause proteome hyposuccinylation and metabolic remodeling

23. Prophylactic Corticosteroid Use with Axicabtagene Ciloleucel (Axi-Cel) in Patients (Pts) with Relapsed/Refractory Large B-Cell Lymphoma (R/R LBCL): 2-Year Follow-up of ZUMA-1 Cohort 6

24. Low Incidence of Fungal Infections after Chimeric Antigen Receptor T-Cell Therapy for Non-Hodgkin Lymphoma in an Endemic Region for Coccidioidomycosis

25. THERMAL BIOLOGY OF A POPULATION OF Xenosaurus newmanorum (SQUAMATA: XENOSAURIDAE) FROM XILITLA, SAN LUIS POTOSÍ, MEXICO: DO THEY ACTIVELY THERMOREGULATE?

28. Blinding assessment of manual therapy interventions of the back in Swiss graduate students: a blinding feasibility randomized controlled trial

29. Supplementary Figure S4 from Beneficial Effects of Mifepristone Treatment in Patients with Breast Cancer Selected by the Progesterone Receptor Isoform Ratio: Results from the MIPRA Trial

30. Supplementary Table S5 from Beneficial Effects of Mifepristone Treatment in Patients with Breast Cancer Selected by the Progesterone Receptor Isoform Ratio: Results from the MIPRA Trial

31. Supplementary Figure S5 from Beneficial Effects of Mifepristone Treatment in Patients with Breast Cancer Selected by the Progesterone Receptor Isoform Ratio: Results from the MIPRA Trial

32. Supplementary Table S2 from Beneficial Effects of Mifepristone Treatment in Patients with Breast Cancer Selected by the Progesterone Receptor Isoform Ratio: Results from the MIPRA Trial

33. Supplementary Table S1 from Beneficial Effects of Mifepristone Treatment in Patients with Breast Cancer Selected by the Progesterone Receptor Isoform Ratio: Results from the MIPRA Trial

34. Supplementary Table S8 from Beneficial Effects of Mifepristone Treatment in Patients with Breast Cancer Selected by the Progesterone Receptor Isoform Ratio: Results from the MIPRA Trial

35. Data from Beneficial Effects of Mifepristone Treatment in Patients with Breast Cancer Selected by the Progesterone Receptor Isoform Ratio: Results from the MIPRA Trial

36. Supplementary Figure S3 from Beneficial Effects of Mifepristone Treatment in Patients with Breast Cancer Selected by the Progesterone Receptor Isoform Ratio: Results from the MIPRA Trial

37. Supplementary Table S4 from Beneficial Effects of Mifepristone Treatment in Patients with Breast Cancer Selected by the Progesterone Receptor Isoform Ratio: Results from the MIPRA Trial

38. Supplementary Table S7 from Beneficial Effects of Mifepristone Treatment in Patients with Breast Cancer Selected by the Progesterone Receptor Isoform Ratio: Results from the MIPRA Trial

39. Supplementary Table S6 from Beneficial Effects of Mifepristone Treatment in Patients with Breast Cancer Selected by the Progesterone Receptor Isoform Ratio: Results from the MIPRA Trial

40. Supplementary Methods from Beneficial Effects of Mifepristone Treatment in Patients with Breast Cancer Selected by the Progesterone Receptor Isoform Ratio: Results from the MIPRA Trial

41. Supplementary Figure S6 from Beneficial Effects of Mifepristone Treatment in Patients with Breast Cancer Selected by the Progesterone Receptor Isoform Ratio: Results from the MIPRA Trial

42. Supplementary Figure S2 from Beneficial Effects of Mifepristone Treatment in Patients with Breast Cancer Selected by the Progesterone Receptor Isoform Ratio: Results from the MIPRA Trial

43. Supplementary Figure S1 from Beneficial Effects of Mifepristone Treatment in Patients with Breast Cancer Selected by the Progesterone Receptor Isoform Ratio: Results from the MIPRA Trial

45. Feedback control of organ size precision is mediated byBMP2-regulated apoptosis in theDrosophilaeye

46. Novel epigenetic based differentiation therapy for Acute Myeloid Leukemia

47. Exploring News Tagging on Spanish Digital Press

48. Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma

49. Bitcoin como activo de resguardo ante incertidumbres financieras, con enfoque en la COVID-19 en EUA

Catalog

Books, media, physical & digital resources